FUSAROLI, MICHELE

FUSAROLI, MICHELE  

DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE  

Dottorandi  

Mostra records
Risultati 1 - 20 di 38 (tempo di esecuzione: 0.033 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
Adrenal Insufficiency with Anticancer Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor Receptor: Analysis of the FDA Adverse Event Reporting System Raschi E.; Fusaroli M.; Giunchi V.; Repaci A.; Pelusi C.; Mollica V.; Massari F.; Ardizzoni A.; P...oluzzi E.; Pagotto U.; Di Dalmazi G. 2022-01-01 CANCERS - 1.01 Articolo in rivista cancers-14-04610-v2 (2).pdf
Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System Gaimari A.; Fusaroli M.; Raschi E.; Baldin E.; Vignatelli L.; Nonino F.; De Ponti F.; Mandrioli J....; Poluzzi E. 2022-01-01 DRUG SAFETY - 1.01 Articolo in rivista Amyotrophic.pdf
Assessment of Reported Adverse Events After Interchanging Between TNF-α Inhibitor Biosimilars in the WHO Pharmacovigilance Database Pauline O.; Robert M.; Bernardeau C.; Hlavaty A.; Fusaroli M.; Roustit M.; Cracowski J.L.; Khouri C. 2023-01-01 BIODRUGS - 1.01 Articolo in rivista -
Authors’ Reply to Robert P. Giugliano and Colleagues’ Comment on: “Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance” Raschi, Emanuel; Fusaroli, Michele; Diemberger, Igor; Poluzzi, Elisabetta 2021-01-01 DRUG SAFETY - 1.04 Replica / breve intervento (e simili) -
Behavioral excess and disruptive conduct: A historical and taxonomic approach to the origin of the ‘impulse control disorders’ diagnostic construct Fusaroli M.; Pellegrini L.; Fusaroli R.; Raschi E.; Menchetti M.; Poluzzi E. 2023-01-01 ADDICTION - 1.01 Articolo in rivista Behavioral excess and disruptive conduct A historical and taxonomic approach to the origin of the 'impulse control disorders' diagnostic construct.pdf
Bone fracture as a novel immune-related adverse event with immune checkpoint inhibitors: Case series and large-scale pharmacovigilance analysis Filippini D.M.; Gatti M.; Di Martino V.; Cavalieri S.; Fusaroli M.; Ardizzoni A.; Raschi E.; Lici...tra L. 2021-01-01 INTERNATIONAL JOURNAL OF CANCER - 1.01 Articolo in rivista Intl Journal of Cancer - 2021 - Filippini - Bone fracture as a novel immune‐related adverse event with immune checkpoint.pdfIJC-149-675-s001.pdf
Capmatinib-Induced Liver Injury as Emerging Toxicity of MET Inhibitors in Patients With NSCLC Pretreated With Immune Checkpoint Inhibitors Sisi, Monia; Vitale, Giovanni; Fusaroli, Michele; Riefolo, Mattia; Giunchi, Valentina; D’Errico, ...Antonietta; Ardizzoni, Andrea; Raschi, Emanuel; Gelsomino, Francesco 2023-01-01 JTO CLINICAL AND RESEARCH REPORTS - 1.01 Articolo in rivista Sisi et al. JTO CCR 23.pdfSisi et al. JTO CCR supplementary 23.pdf
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians Raschi, Emanuel; Rossi, Simone; De Giglio, Andrea; Fusaroli, Michele; Burgazzi, Flavio; Rinaldi, ...Rita; Potena, Luciano 2023-01-01 DRUG SAFETY - 1.01 Articolo in rivista Raschi et al., Drug Safety Cardiotoxicity ICI 2023.pdf40264_2023_1320_MOESM1_ESM.pdf
Challenges and Opportunities in Accessing and Analysing FAERS Data: A Call Towards a Collaborative Approach Giunchi, Valentina; Fusaroli, Michele; Hauben, Manfred; Raschi, Emanuel; Poluzzi, Elisabetta 2023-01-01 DRUG SAFETY - 1.01 Articolo in rivista -
Crystal nephropathy and amoxicillin: insights from international spontaneous reporting systems Gatti M.; Fusaroli M.; Raschi E.; Capelli I.; Poluzzi E.; De Ponti F. 2022-01-01 JN. JOURNAL OF NEPHROLOGY - 1.01 Articolo in rivista 40620_2021_1191_MOESM2_ESM.pptx40620_2021_1191_MOESM1_ESM.pptx
Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment Raschi E.; Fusaroli M.; Ardizzoni A.; Poluzzi E.; De Ponti F. 2021-01-01 BREAST CANCER RESEARCH AND TREATMENT - 1.01 Articolo in rivista s10549-020-06001-w.pdf
Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System Fusaroli M.; Pelletti G.; Giunchi V.; Pugliese C.; Bartolucci M.; Necibi E.N.; Raschi E.; De Pont...i F.; Pelotti S.; Poluzzi E. 2023-01-01 DRUG SAFETY - 1.01 Articolo in rivista s40264-022-01269-x.pdf40264_2022_1269_MOESM1_ESM.pdf
Development of a Network-Based Signal Detection Tool: The COVID-19 Adversome in the FDA Adverse Event Reporting System Fusaroli M.; Raschi E.; Gatti M.; De Ponti F.; Poluzzi E. 2021-01-01 FRONTIERS IN PHARMACOLOGY - 1.01 Articolo in rivista fphar-12-740707.pdfDataSheet1.zip
Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance Raschi E.; Fusaroli M.; Diemberger I.; Poluzzi E. 2020-01-01 DRUG SAFETY - 1.01 Articolo in rivista -
Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS Fusaroli M.; Giunchi V.; Battini V.; Puligheddu S.; Khouri C.; Carnovale C.; Raschi E.; Poluzzi E. 2024-01-01 DRUG SAFETY - 1.01 Articolo in rivista s40264-023-01391-4.pdf40264_2023_1391_MOESM1_ESM.docx
Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study Fusaroli M.; Giunchi V.; Battini V.; Gringeri M.; Rimondini R.; Menchetti M.; Radice S.; Pozzi M....; Nobile M.; Clementi E.; De Ponti F.; Carnovale C.; Raschi E.; Poluzzi E. 2023-01-01 PSYCHIATRY AND CLINICAL NEUROSCIENCES - 1.01 Articolo in rivista Exploring the underlying mechanisms of drug-induced impulse control disorders a pharmacovigilance-pharmacodynamic study.pdf
Identifying Medications Underlying Communication Atypicalities in Psychotic and Affective Disorders: A Pharmacovigilance Study Within the FDA Adverse Event Reporting System Fusaroli M.; Simonsen A.; Borrie S.A.; Low D.M.; Parola A.; Raschi E.; Poluzzi E.; Fusaroli R. 2023-01-01 JOURNAL OF SPEECH, LANGUAGE, AND HEARING RESEARCH - 1.01 Articolo in rivista 2022.09.05.22279609v3.full.pdf
Immune Checkpoint Inhibitors and Pregnancy: Analysis of the VigiBase® Spontaneous Reporting System Noseda, Roberta; Müller, Laura; Bedussi, Francesca; Fusaroli, Michele; Raschi, Emanuel; Ceschi, A...lessandro 2022-01-01 CANCERS - 1.01 Articolo in rivista 157_ICI_Pregnancy_Cancers_2023.pdfcancers-15-00173-s001.zip
Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System Fusaroli M.; Raschi E.; Giunchi V.; Menchetti M.; Rimondini Giorgini R.; De Ponti F.; Poluzzi E. 2022-01-01 INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY - 1.01 Articolo in rivista pyac031-10.pdfpyac031_suppl_supplementary_material.pdf
Impulsive conditions in Parkinson's disease: A pharmacosurveillance-supported list Fusaroli M.; Raschi E.; Contin M.; Sambati L.; Menchetti M.; Fioritti A.; Poluzzi E. 2021-01-01 PARKINSONISM & RELATED DISORDERS - 1.01 Articolo in rivista -